Market Closed -
Japan Exchange
02:00:00 2024-04-25 am EDT
5-day change
1st Jan Change
3,724
JPY
+0.11%
+2.00%
+15.58%
Cellusion Inc. announced that it has received funding from Toho Holdings Co., Ltd.
Cellusion Inc. announced that it has received a round of funding from new investor Toho Holdings Co., Ltd. on October 20, 2021.
Tranche Update on Toho Holdings Co., Ltd.'s Equity Buyback Plan announced on September 15, 2023.
Mar. 07
CI
Toho Holdings Co., Ltd.'s Equity Buyback announced on September 15, 2023, has closed with 1,838,800 shares, representing 2.87% for ¥5,999.94 million.
Mar. 06
CI
Tranche Update on Toho Holdings Co., Ltd.'s Equity Buyback Plan announced on September 15, 2023.
Jan. 04
CI
Toho Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Full Year Ending March 2024
Nov. 09
CI
Toho Holdings Co., Ltd. Announces Dividend for the Second Quarter of Year Ending March 31, 2024, Payable on December 1, 2023, Provides Dividend Guidance for the Year Ending 2024
Nov. 09
CI
MICIN, Inc. announced that it has received ¥4 billion in funding from MTG Ventures Co., Ltd., Alfresa Corporation, Toho Holdings Co., Ltd. and other investors
23-10-04
CI
Tranche Update on Toho Holdings Co., Ltd.'s Equity Buyback Plan announced on September 15, 2023.
23-10-02
CI
Toho Holdings Co., Ltd. announces an Equity Buyback for 2,500,000 shares, representing 3.87% for ¥6,000 million.
23-09-15
CI
Toho Holdings Co., Ltd. authorizes a Buyback Plan.
23-09-14
CI
United Immunity, Co., Ltd. announced that it has received ¥800 million in funding from Toho Holdings Co., Ltd., The University of Tokyo Edge Capital Partners Co., Ltd., Saisei Ventures LLC, Venture Labo Investment
23-09-10
CI
Toho Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending September 2023 and Fiscal Year Ending March 31, 2024
23-08-04
CI
Toho Holdings Co., Ltd. Provides Dividend Guidance for the Second Quarter and Year Ending March 31, 2024
23-08-04
CI
Tranche Update on Toho Holdings Co., Ltd.'s Equity Buyback Plan announced on May 31, 2023.
23-05-31
CI
Toho Holdings Co., Ltd.'s Equity Buyback announced on May 31, 2023, has closed with 2,360,300 shares, representing 3.52% for ¥5,999.88 million.
23-05-31
CI
Toho Holdings Co., Ltd. announces an Equity Buyback for 3,000,000 shares, representing 4.48% for ¥6,000 million.
23-05-31
CI
Toho Holdings Co., Ltd. authorizes a Buyback Plan.
23-05-30
CI
Toho Holdings Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023
23-05-12
CI
Toho Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Half Year Ending September 2023 and Fiscal Year Ending March 2024
23-05-12
CI
Toho Holdings Co., Ltd. Announces Dividend for the Year Ended March 31, 2023, Payable on June 9, 2023; Provides Dividend Guidance for the Second Quarter and Fiscal Year Ending March 31, 2024
23-05-12
CI
Toho Holdings Co., Ltd. Provides Dividend Guidance for the Year Ending March 2023
23-02-08
CI
Toho Holdings Co., Ltd. Provides Earnings Guidance for the Fiscal Year Ending March 2023
23-02-08
CI
Tranche Update on Toho Holdings Co., Ltd.'s Equity Buyback Plan announced on November 21, 2022.
22-11-21
CI
Toho Holdings Co., Ltd.'s Equity Buyback announced on November 21, 2022, has closed with 3,573,400 shares, representing 5.07% for ¥7,389.79 million.
22-11-21
CI
Toho Holdings Co., Ltd. announces an Equity Buyback for 3,850,000 shares, representing 5.46% for ¥8,000 million.
22-11-21
CI
Toho Holdings Co., Ltd. authorizes a Buyback Plan.
22-11-20
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Toho Holdings Co Ltd is a Japan-based company mainly engaged in the pharmaceutical wholesale business. The Company operates through five business segments. The Pharmaceutical Wholesale segment purchases pharmaceuticals and medical-related products from pharmaceutical manufacturers and sells them to hospitals, clinics and dispensing pharmacies. It is also engaged in the provision of data processing system and rental of real estate. The Dispensing Pharmacy segment is engaged in the management of insurance dispensing pharmacies and dispensing pharmacies. The Pharmaceutical Manufacture and Sale segment is engaged in the manufacture and sale of generic drugs and contract manufacturing of injectable drugs. The Clinical Trial Facility Support segment is engaged in the provision of support for clinical trial facilities. The Information Equipment Sales segment is engaged in the planning and sale of information processing equipment.
More about the company
Last Close Price
3,720
JPY
Average target price
3,152
JPY
Spread / Average Target
-15.26%
Consensus
1st Jan change
Capi.
+15.58% 1.47B +15.90% 70.36B +3.23% 25.18B +6.36% 8.61B +6.10% 8.14B -21.85% 7.83B -0.37% 4.56B +17.40% 4.32B -0.14% 4.06B -3.44% 3.87B
Pharmaceuticals Wholesale
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
TOHO HOLDINGS CO., LTD. 
